Cell & Gene therapy
May 11, 2020
General chances and challenges of a personalized therapy approach: CAR-T cell therapy
Michael Eder
The term CGT stands for Cell and Gene Therapy and describes a range of new personalized therapies that are promising in the treatment of some diseases. For which diseases is the therapy suitable?
February 11, 2019
Why the CAR-T cell therapy can be a cause for human drama
Michael Eder
According to information from the biopharmaceutical industry, the loss rate for CAR-T cell therapies is over 1%. This means that it can be assumed that currently only 99 out of 100 people receive a fully functional Car-T therapy. Read here!
February 8, 2019
CAR-T cell therapies: The therapy is slowly coming to the market – but does it also usefully reach the patient?
Michael Eder
The National Health Service (NHS) of Great Britain, confirms the use of CAR-T Cell Therapy Kymriah on an 11-year-old leukaemia patient. However, it is not certain whether the vital therapy will make its way into society. Read it for yourself!
